Expasy logo

ENZYME

ENZYME entry: EC 1.14.13.181

Accepted Name
13-deoxydaunorubicin hydroxylase
Reaction catalysed
  • 13-deoxydaunorubicin + H(+) + NADPH + O2 <=> 13-dihydrodaunorubicin + H2O + NADP(+)
  • 13-dihydrodaunorubicin + H(+) + NADPH + O2 <=> daunorubicin + 2 H2O + NADP(+)
Comment(s)
The enzymes from the Gram-positive bacteria Streptomyces sp. C5 and Streptomyces peucetius show broad substrate specificity for structures based on an anthracycline aglycone, but have a strong preference for 4-methoxy anthracycline intermediates (13-deoxydaunorubicin and 13-dihydrodaunorubicin) over their 4-hydroxy analogs (13-deoxycarminomycin and 13-dihydrocarminomycin), as well as a preference for substrates hydroxylated at the C-13 rather than the C-14 position.
Cross-references
BRENDA1.14.13.181
EC2PDB1.14.13.181
ExplorEnz1.14.13.181
PRIAM enzyme-specific profiles1.14.13.181
KEGG Ligand Database for Enzyme Nomenclature1.14.13.181
IUBMB Enzyme Nomenclature1.14.13.181
IntEnz1.14.13.181
MEDLINEFind literature relating to 1.14.13.181
MetaCyc1.14.13.181
Rhea expert-curated reactions1.14.13.181
UniProtKB/Swiss-Prot
Q93MI2, DOXA_STRC0Q9ZAU3, DOXA_STRPEQ59971, DOXA_STRS5

View entry in original ENZYME format
View entry in raw text format (no links)
All UniProtKB/Swiss-Prot entries referenced in this entry, with possibility to download in different formats, align etc.
All ENZYME / UniProtKB/Swiss-Prot entries corresponding to 1.14.13.-
All ENZYME / UniProtKB/Swiss-Prot entries corresponding to 1.14.-.-
All ENZYME / UniProtKB/Swiss-Prot entries corresponding to 1.-.-.-